Stem Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stem Cell stocks.

Stem Cell Stocks Recent News

Date Stock Title
May 17 CLDI Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
May 17 CYRX Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
May 16 FATE Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
May 16 CELC Celcuity Inc (CELC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
May 16 OCX OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript
May 15 CELC Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
May 15 IPSC Century Therapeutics files to sell 15.87M shares of common stock for holders
May 15 FBLG FibroBiologics Announces 2024 Annual Meeting of Stockholders
May 15 OCX OncoCyte GAAP EPS of -$1.13 misses by $0.46, revenue of $0.18M misses by $0.17M
May 15 CELC Celcuity Non-GAAP EPS of -$0.59
May 15 OCX Oncocyte Reports First Quarter 2024 Financial Results
May 15 CELC Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
May 15 FBLG FibroBiologics GAAP EPS of -$0.27
May 15 CLDI Calidi Biotherapeutics reports Q1 results
May 15 BRTX BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
May 15 ALLO Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 BRTX BioRestorative Therapies reports Q1 results
May 14 BRTX BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript
May 14 OCX OncoCyte Q1 2024 Earnings Preview
May 14 FBLG FibroBiologics Files 2024 First Quarter Report
Stem Cell

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.
There are three known accessible sources of autologous adult stem cells in humans:
bone marrow, adipose tissue, and blood. Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.
Adult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies. Research into stem cells grew out of findings by Ernest A. McCulloch and James E. Till at the University of Toronto in the 1960s.

Browse All Tags